Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs

Fiche du document

Type de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhealeco.2020.102371

Collection

Archives ouvertes

Licences

http://creativecommons.org/licenses/by/ , info:eu-repo/semantics/OpenAccess




Citer ce document

Vincenzo Carrieri et al., « Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs », HAL-SHS : économie et finance, ID : 10.1016/j.jhealeco.2020.102371


Métriques


Partage / Export

Résumé En

Governments worldwide are increasingly concerned about the booming use of CBD (cannabidiol) products. However, we know little about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using unique and high-frequency data on prescription drug sales and by exploiting the staggered local availability of the new product in each Italian province, we document a significant substitution effect between light cannabis and anxiolytics, sedatives, opioids, anti-depressants and anti-psychotics. Results are informative for regulators and suggest that bans on light cannabis use would disregard the needs of patients to seek effective reliefs of their symptoms.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Sur les mêmes disciplines

Exporter en